Skip to main content
PMC home page
Atencion Primaria logoLink to Atencion Primaria
. 2008 Dec 20;40(8):413–417. [Article in Spanish] doi: 10.1157/13125407

Revisión de tests de medición del cumplimiento terapéutico utilizados en la práctica clínica

Miguel Ángel Rodríguez Chamorro a,⁎, Emilio García-Jiménez b, Pedro Amariles c, Alfonso Rodríguez Chamorro d, María José Faus e
PMCID: PMC7713441  PMID: 18755102

The content is available as a PDF (108.7 KB).

Bibliografía

  • 1.Rodríguez Chamorro M.A., Rodríguez Chamorro A., García Jiménez E. Incumplimiento terapéutico en pacientes en seguimiento farmacoterapéutico mediante el método Dáder. Pharmaceutical Care España. 2006;8:62–68. [Google Scholar]
  • 2.Blackwell B. Drug therapy compliance. N Engl J Med. 1973;289:249–252. doi: 10.1056/NEJM197308022890506. [DOI] [PubMed] [Google Scholar]
  • 3.Roca-Cusachs A. Estrategias de intervención para mejorar el cumplimiento. Med Clin (Barc) 2001;116(Suppl 2):56–62. [Google Scholar]
  • 4.García Jiménez E. Incumplimiento como causa de problema relacionado con medicamentos en el seguimiento farmacoterapéutico [Tesis Doctoral]. Granada; 2003.
  • 5.WHO. Adherence to long-therm therapies. Evidence for action. Geneve: World Health Organization; 2004.
  • 6.Palop Larrea V., Martínez Mir I. Adherencia al tratamiento en el paciente anciano. Información Terapéutic del Sistema Nacional de Salud. 2004;28:113–120. [Google Scholar]
  • 7.Donovan J.L. Patient decision making. The missing ingredient in compliance research. Int J Technol Assess Health Care. 1995;11:443–455. doi: 10.1017/s0266462300008667. [DOI] [PubMed] [Google Scholar]
  • 8.Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74. doi: 10.1097/00005650-198601000-00007. [DOI] [PubMed] [Google Scholar]
  • 9.Val Jiménez A., Amorós Ballestero G., Martínez P., Fernández M.L., León M. Estudio descriptivo del cumplimiento del tratamiento farmacológico antihipertensivo y validación del test de Morisky y Green. Aten Primaria. 1992;10:767–770. [PubMed] [Google Scholar]
  • 10.Knobel H., Alonso J., Casado J.L., Collazos J., González J., Ruiz I. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS. 2002;16:605–613. doi: 10.1097/00002030-200203080-00012. [DOI] [PubMed] [Google Scholar]
  • 11.Thompson K., Kulkarni J., Segejew A.A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42:241–247. doi: 10.1016/s0920-9964(99)00130-9. [DOI] [PubMed] [Google Scholar]
  • 12.Krapek K., King K., Warren S.S., George K.G., Caputo D.A., Mihelich K. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother. 2004;38:1357–1361. doi: 10.1345/aph.1D612. [DOI] [PubMed] [Google Scholar]
  • 13.Chang M.C., Chang Y.C., Chiou J.F., Tsou T.S., Lin C.C. Overcoming patient-related barriers to cancer pain management for home care patients: a pilot study. Cancer Nurs. 2002;25:470–476. doi: 10.1097/00002820-200212000-00012. [DOI] [PubMed] [Google Scholar]
  • 14.Turbi C., Herrero-Beaumont G., Acebes J.C., Torrijos A., Grana J., Miguélez R. Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective nonrandomized, observational study. Clin Ther. 2004;26:245–256. doi: 10.1016/s0149-2918(04)90023-9. [DOI] [PubMed] [Google Scholar]
  • 15.Davis N.J., Billet H.H., Cohen H.W., Arnsten J.H. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother. 2005;39:632–636. doi: 10.1345/aph.1E464. [DOI] [PubMed] [Google Scholar]
  • 16.Jabary N.S., Castrodeza J., Monfa J.M., Sousa F., Plagaro M.F., Martin A. Validación de un nuevo test para determinar el cumplimiento terapéutico en pacientes hipertensos: test Hermes. Hipertensión. 1999;16:298–303. [Google Scholar]
  • 17.Herrera Carranza J. El incumplimiento terapéutico como problema relacionado con medicamentos diferenciado. Pharm Care Esp. 2001;3:446–448. [Google Scholar]
  • 18.Ventura-Cerdá J.M., Mínguez-Gallego C., Fernández-Villalba E.M., Alós-Almiñana M., Andrés-Soler J. Escala simplificada para detectar problemas de adherencia (ESPA) al tratamiento retroviral. Farm Hosp. 2006;30:171–176. doi: 10.1016/s1130-6343(06)73968-x. [DOI] [PubMed] [Google Scholar]
  • 19.George J., Kong D.C.M., Thoman R., Steward K. Factors associated with medication nonadherence in patients with COPD. Chest. 2005;128:3198–3204. doi: 10.1378/chest.128.5.3198. [DOI] [PubMed] [Google Scholar]
  • 20.Starsvad B.L., Chewning B.A., Sleath B.L., Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113–124. doi: 10.1016/s0738-3991(98)00107-4. [DOI] [PubMed] [Google Scholar]
  • 21.Krass I., Taylor S.J., Smith C., Armour C.L. Impact on medication use and adherence of Australian pharmacists’ diabetes care services. J Am Pharm Assoc. 2005;45:33–40. doi: 10.1331/1544345052843093. [DOI] [PubMed] [Google Scholar]
  • 22.Gwenn W., Nelemans P., Van Wijk B., Broers N., Schouten J., Prins M. Determinants of poor adherence in hypertensive patients: Development and validation of the «Maastrich Utrecht Adherence in Hypertension (MUAH)-questionnaire». Patient Educ Couns. 2006;64:151–158. doi: 10.1016/j.pec.2005.12.010. [DOI] [PubMed] [Google Scholar]
  • 23.Cirici R. La adherencia al tratamiento de los pacientes psicóticos. Rev Psiq Fac Med Barna. 2002;29:232–238. [Google Scholar]
  • 24.Weiden Rapkin B., Mott T., Zygmunt A., Goldman D., Horvitz-Lennon M., Frances A. Rating of Medication Influences (ROMI). Scale in schizopfrenia. Schiz Bull. 1994;20:297–310. doi: 10.1093/schbul/20.2.297. [DOI] [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES